Hepatoprotective effect of Fomes fomentarius extract against carbon tetrachloride-induced acute liver injury in rat

Document Type : Original Article


1 School of Pharmacy, International Campus, Tehran University of Medical Sciences, Tehran, Iran

2 Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran


Background and aims: Medicinal mushrooms are known for their potential for the treatment of various diseases such as cancer and gastrointestinal disorders. Fomes fomentarius is a fungus belonging to the Polyporaceae family with anti-inflammatory, antioxidant, antidiabetic, and antitumor effects.
Methods: This study aimed to investigate the hepatoprotective effect of F. fomentarius extract in a rat model of carbon tetrachloride (CCl4)-induced toxicity along with its scavenging activity against 2,2-diphenyl-1-picrylhydrazyl.
Results: Better antioxidant activity was obtained for ethanol extract of the fungus (IC50: 206.20 µg/mL) compared with its aqueous extract (IC50: 414.33 µg/mL). Levels of alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase, and alkaline phosphatase decreased after administration of the ethanol extract especially at 100 mg/kg compared with higher doses (200 and 400 mg/kg). 
Conclusion: Treatment with the lower dose of the extract reduced alkaline phosphatase more pronouncedly than silymarin, indicating the beneficial properties of the fungus for biliary tract diseases. Histopathological findings also showed that F. fomentarius extract at the lower dose could protect against CCl4-induced liver injury, and the mechanism may be related to its antioxidant activity.


1.Taub R. Hepatoprotection via the IL-6/Stat3 pathway. J Clin Invest. 2003;112(7):978-80.
2.Chen IS, Chen YC, Chou CH, Chuang RF, Sheen LY, Chiu CH. Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis. J Sci Food Agric. 2012;92(7):1441-7.
3.Kolundžić M, Grozdanić ND, Dodevska M, Milenković M, Sisto F, Miani A, et al. Antibacterial and cytotoxic activities of wild mushroom Fomes fomentarius (L.) Fr., Polyporaceae. Ind Crops Prod. 2016;79:110-5.
4.Chen W, Zhao Z, Chen S-F, Li Y-Q. Optimization for the production of exopolysaccharide from Fomes fomentarius in submerged culture and its antitumor effect in vitro. Bioresour Technol. 2008;99(8):3187-94.
5.Senyuk OF, Gorovoj LF, Beketova GV, Savichuk NO, Rytik PG, Kucherov II, et al. Anti-infective properties of the melanin-glucan complex obtained from medicinal tinder bracket mushroom, Fomes fomentarius (L.: Fr.) Fr.(Aphyllophoromycetideae). ‎Int J Med Mushrooms. 2011;13(1).
6.Park Y-M, Kim I-T, Park H-J, Choi J-W, Park K-Y, Lee J-D, et al. Anti-inflammatory and anti-nociceptive effects of the methanol extract of Fomes fomentarius. Biol Pharm Bull. 2004;27(10):1588-93.
7.Vazirian M, Dianat S, Manayi A, Ziari R, Mousazadeh A, Habibi E, et al. Anti-inflammatory effect, total polysaccharide, total phenolics content and antioxidant activity of the aqueous extract of three basidiomycetes. RJP. 2014;1(1):15-21.
8.Grienke U, Zöll M, Peintner U, Rollinger JM. European medicinal polypores–A modern view on traditional uses. J Ethnopharmacol. 2014;154(3):564-83.
9.Nowacka N, Nowak R, Drozd M, Olech M, Los R, Malm A. Antibacterial, antiradical potential and phenolic compounds of thirty-one polish mushrooms. PLoS One. 2015;10(10):e0140355.
10.Khalaf AAA, Mekawy MEM, Moawad MS, Ahmed AM. Comparative study on the protective effect of some antioxidants against CCl4 hepatotoxicity in rats. Egypt J Nat Toxins. 2009;6(1):59-82.
11.Zeinvand-Lorestani H, Nili-Ahmadabadi A, Balak F, Hasanzadeh G, Sabzevari O. Protective role of thymoquinone against paraquat-induced hepatotoxicity in mice. Pestic Biochem Phys. 2018;148:16-21.
12.Rusu M, Tamas M, Puica C, Roman I, Sabadas M. The hepatoprotective action of ten herbal extracts in CCl4 intoxicated liver. Phytother Res. 2005;19(9):744-9.
13.Shahjahan M, Sabitha K, Jainu M, Devi CS. Effect of Solanum trilobatum against carbon tetra chloride induced hepatic damage in albino rats. Indian J Med Res. 2004;120:194-8.
14.Tetangco EP, Shah N, Arshad HM, Raddawi H. Markedly elevated liver enzymes in choledocholithiasis in the absence of hepatocellular disease: Case series and literature review. J Investig Med High Impact Case Rep. 2016;4(2):2324709616651092.
15.Chen W, He Y, Jiang D-w, Hou D-y, Mo L-f, Shen X-r. Protective effect of Fomes fomentarius extracts on CCl4-induced acute liver injury in mice. Shizhen Guo Yi Guo Yao. 2013;3.
16.Choe J-H, Yi Y-J, Lee M-S, Seo D-W, Yun B-S, Lee S-M. Methyl 9-Oxo-(10 E, 12 E)-octadecadienoate isolated from Fomes fomentarius attenuates lipopolysaccharide-induced inflammatory response by blocking phosphorylation of STAT3 in murine macrophages. Mycobiology. 2015;43(3):319-26.
17.Seo D-W, Yi Y-J, Lee M-S, Yun B-S, Lee S-M. Differential modulation of lipopolysaccharide-induced inflammatory cytokine production by and antioxidant activity of fomentariol in RAW264. 7 cells. Mycobiology. 2015;43(4):450-7.
18.Maljurić N, Golubović J, Ravnikar M, Žigon D, Štrukelj B, Otašević B. Isolation and determination of fomentariol: Novel potential antidiabetic drug from fungal material. J Anal Methods Chem. 2018;2018:2434691.
19.Galati G, O'brien PJ. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic Biol Med. 2004;37(3):287-303.
20.Gupta Y, Sharma M, Chaudhary G. Pyrogallol-induced hepatotoxicity in rats: a model to evaluate antioxidant hepatoprotective agents. Methods Find Exp Clin Pharmacol. 2002;24(8):497-500.
21.Neuman MG, Koren G, Tiribelli C. In vitro assessment of the ethanol-induced hepatotoxicity on HepG2 cell line. Biochemical and biophysical research communications. 1993;197(2):932-41.
22.Mani V, Arivalagan S, Siddique AI, Namasivayam N. Antioxidant and anti-inflammatory role of zingerone in ethanol-induced hepatotoxicity. Molecular and cellular biochemistry. 2016;421(1):169-81.